PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NYU Langone Health chair of ophthalmology, Dr. Kathryn Colby, honored with Castroviejo Medal at AAO 2025

2025-10-17
(Press-News.org) ORLANDO, FLORIDA, OCTOBER 17, 2025—NYU Langone Health ophthalmology faculty present their latest research at this year’s annual meeting of the American Academy of Ophthalmology (AAO), where Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor and chair of the Department of Ophthalmology at NYU Grossman School of Medicine, will be awarded the prestigious Castroviejo Medal from the Cornea Society. This honor recognizes Dr. Colby’s groundbreaking contributions to the field of ophthalmology, particularly in the promotion, research, and understanding of the cornea.

Among the presentations at AAO in Orlando, October 17 to 20, Dr. Colby will deliver the annual Castroviejo Lecture, named in honor of Ramon Castroviejo, MD, the father of modern corneal transplant surgery and the inspiration for the founding of the Cornea Society. More on her talk and other spotlight presentations by faculty below.

Castroviejo Lecture

Innovation in Ophthalmology: Advances in the Management of Endothelial Corneal Dystrophy

Dr. Colby’s lecture will focus on transformative approaches to treating Fuchs endothelial corneal dystrophy, an area of study Dr. Colby has spent her career advancing. Dr. Colby is a renowned expert in the vision-threatening corneal condition, commonly called Fuchs dystrophy, which is the most common reason for corneal transplant in the United States. Her latest research explores the potential of a surgical procedure, Descemet stripping only (DSO), paired with the targeted therapy Rho kinase inhibitors to stimulate endogenous corneal endothelial cell regeneration. Dr. Colby pioneered DSO as a treatment to allow a patient’s own cells to rejuvenate their cornea, rather than relying on a donor cornea.

“Receiving the Castroviejo Medal is a profound honor, and it emphasizes the importance of advancing treatments that can significantly improve patient outcomes,” said Dr. Colby. “We are at the forefront of developing therapies that could one day eliminate the need for corneal transplants in certain cases.”

Dr. Colby has been devoted to improving the practice of ophthalmology and enhancing the status of women in the field. She’s held leadership positions in several national and international societies, including being a past president of the Cornea Society, and co-authored more than 100 peer-reviewed studies and 7 books.

Instruction Course

New Treatments for Dry Eye and Meibomian Gland Dysfunction

Mina Massaro[MM1] -Giordano, MD, director of the dry eye service for NYU Langone’s Department of Ophthalmology, will instruct on how intense pulse light, or IPL, can be used to treat dry eye. Her study of the practice showcases the effectiveness of this noninvasive therapy in enhancing Meibomian gland function and alleviating symptoms of dry eye.

“This treatment has evolved significantly over the past 20 years, and there are promising advancements that can improve the quality of life for those suffering from dry eye disease,” said Dr. Massaro-Giordano.

Session

Vitreoretinal Surgery: Eye Transplant Surgery

Vaidehi S. Dedania, MD, presents the data acquired while on the surgical team performing the world’s first face and eye transplant surgery at NYU Langone Health and provides an update on the visual and surgical outcomes. The 21-hour procedure achieved eye globe viability with a novel superficial temporal artery to ophthalmic artery vascular connection and direct optic nerve reconnection. Postoperative imaging revealed optic tract integration, but sight restoration remains elusive due to limited optic nerve regeneration.

“This technique effectively allowed the globe of the eye to remain perfused until the external carotid artery was ligated as the last step of the donor procurement,” said Dr. Dedania. “While challenges remain, this first step in understanding an effective surgical approach to transplant will lead to further progress in this area of innovation going forward.”

Dr. Colby, who is also director of the NYU Langone Eye Center, said, “These presentations underscore NYU Langone Health’s commitment to clinicians, researchers, and patients through pioneering research and innovative treatments.”

About NYU Langone Health

NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone No. 1 out of 118 comprehensive academic medical centers across the nation for four years in a row, and U.S. News & World Report recently ranked four of its clinical specialties No. 1 in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across seven inpatient locations, its Perlmutter Cancer Center, and more than 320 outpatient locations in the New York area and Florida. With $15.5 billion in revenue this year, the system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise.

END


ELSE PRESS RELEASES FROM THIS DATE:

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

2025-10-17
BERLIN October 17, 2025 – Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed EGFR-mutated advanced non-small cell lung cancer (NSCLC) compared to osimertinib alone. The finding is based on an analysis of the complete data from the phase 3 global FLAURA2 study, co-led by researchers from Dana-Farber Cancer Institute and Gustave Roussy (Grand Paris, Villejuif, France). Median overall survival was 47.5 months in the osimertinib plus platinum–pemetrexed group versus 37.6 months ...

FAU’s Queen Conch Lab receives prestigious international award

2025-10-17
The Florida Atlantic University Harbor Branch Oceanographic Institute’s Queen Conch Lab, led by research professor Megan Davis, Ph.D., has been named the recipient of the 2025 Responsible Seafood Innovation Award in Aquaculture from the Global Seafood Alliance (GSA). The award honors the Queen Conch Lab’s development of mobile lab hatcheries designed to help restore the threatened Caribbean queen conch. These self-contained, trailer-based hatcheries bring advanced aquaculture capabilities to coastal communities across the Caribbean, many of which lack traditional infrastructure. This innovation is not only helping to rebuild wild ...

Post-traumatic vasospasm: An overlooked threat after brain injury

2025-10-17
A new review published in the Journal of Intensive Medicine on 25 July, 2025 and led by Dr. Alice Jacquens and Dr. Clara Perrault from Pitié Salpêtrière Hospital, Paris, France, sheds light on an under-recognized complication of traumatic brain injury (TBI): post-traumatic vasospasm (PTV). PTV is a sudden narrowing of brain arteries that can lead to stroke and long-term neurological damage. It may affect up to 60% of TBI patients but is often missed, especially in intensive care units where ...

Scientists smash record in stacking semiconductor transistors for large-area electronics

2025-10-17
King Abdullah University of Science and Technology (KAUST; Saudi Arabia) researchers have set a record in microchip design, achieving the first six-stack hybrid CMOS (complementary metal-oxide semiconductor) for large-area electronics. With no other reported hybrid CMOS exceeding two stacks, the feat marks a new benchmark in integration density and efficiency, opening possibilities in electronic miniaturization and performance.  Among microchip technologies, CMOS microchips are found in nearly all electronics, from phones and televisions to satellites and medical devices. Compared with conventional silicon chips, hybrid CMOS microchips hold greater promise ...

Large language models prioritize helpfulness over accuracy in medical contexts

2025-10-17
Large language models (LLMs) can store and recall vast quantities of medical information, but their ability to process this information in rational ways remains variable. A new study led by investigators from Mass General Brigham demonstrated a vulnerability in that LLMs are designed to be sycophantic, or excessively helpful and agreeable, which leads them to overwhelmingly fail to appropriately challenge illogical medical queries despite possessing the information necessary to do so. Findings, published in npj Digital Medicine, demonstrate that targeted training and fine-tuning can ...

In a surprising discovery, scientists find tiny loops in the genomes of dividing cells

2025-10-17
CAMBRIDGE, MA -- Before cells can divide, they first need to replicate all of their chromosomes, so that each of the daughter cells can receive a full set of genetic material. Until now, scientists had believed that as division occurs, the genome loses the distinctive 3D internal structure that it typically forms. Once division is complete, it was thought, the genome gradually regains that complex, globular structure, which plays an essential role in controlling which genes are turned on in a given cell. However, a new study from MIT shows that in fact, this picture is not fully accurate. ...

Printing technique could vastly improve the environmental impact of digital displays

2025-10-17
Electrical engineers at Duke University have demonstrated the ability to print fully functional and recyclable electronics at sub-micrometer scales. The technique could impact the more than $150 billion electronic display industry and its environmental impact while providing a toehold for U.S. manufacturing to gain traction in a vital and quickly growing industry. The research appears October 17 in the journal Nature Electronics. “If we want to seriously increase U.S.-based manufacturing in areas dominated by global competitors, we need transformational technologies,” said Aaron ...

‘Skinny fat’ linked to silent artery damage, McMaster study reveals

2025-10-17
Hamilton, ON (October 17, 2025) – A new study led by researchers at McMaster University reveals that hidden fat deep inside the abdomen and liver may quietly damage arteries, even in people who appear healthy.   The findings, published in Communications Medicine on October 17, 2025, challenge the long-standing reliance on body-mass index (BMI) as a measure of obesity and offer fresh insight into how hidden fat contributes to heart disease.  Visceral fat (the kind that wraps ...

Sulfated yeast rises to the challenge facing rare earth metals

2025-10-17
Ever wonder what happens to those old, broken electronics after tossing them? How about how new ones are being produced despite dwindling resources? The seemingly endless supply of gadgets hides an increasingly critical problem, limited raw resources. Electronics, optical fibers, and superconducting materials heavily rely on rare earth metals, but such limited resources lack innovative recycling solutions. Various methods do exist for metal recovery, but technology with low environmental impact and costs is rising in demand. Fortunately, an answer may have been found in the common kitchen ingredient, baker’s yeast. ...

Global analysis reveals how biochar supercharges composting and cuts greenhouse gases

2025-10-17
A new study by researchers from Sichuan Agricultural University and international collaborators provides the most comprehensive evidence to date that biochar, a charcoal-like substance made from organic materials, plays a crucial role in faster, cleaner composting. By analyzing data from 125 studies across the world, the research team showed that adding biochar to composting systems significantly boosts compost quality while slashing harmful greenhouse gas emissions. The findings, published in Biochar X, could help scale up sustainable waste management and climate-friendly agriculture. “Biochar ...

LAST 30 PRESS RELEASES:

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

[Press-News.org] NYU Langone Health chair of ophthalmology, Dr. Kathryn Colby, honored with Castroviejo Medal at AAO 2025